Kenvue Inc. (KVUE) Stock Analysis & Investment Frameworks
Kenvue Inc. (KVUE) stock analysis on Invetso. Review Kenvue Inc.’s key financial metrics, company overview and 10 institutional-grade investment frameworks including SWOT Analysis, Economic Moat, Porter’s Five Forces and the Invetso Quality Score.
Kenvue Inc. Company Overview
- Exchange: New York Stock Exchange
- Sector: Consumer Defensive
- Industry: Household & Personal Products
- Country: US
Kenvue Inc. Key Financial Metrics
- Market Cap: $36.57B
- Revenue: $15.12B
- P/E Ratio: 24.73
- ROE: 15.58%
- ROIC: 10.07%
- Dividend Yield: 5.48%
About Kenvue Inc.
Kenvue Inc. functions as a global leader in the consumer health sector. The company structures its operations across three primary divisions: Self Care, Skin Health and Beauty, and Essential Health. Within the Self Care unit, it offers a diverse range of products for common conditions like coughs, colds, and allergies, in addition to pain relief, digestive health, and smoking cessation aids, featuring prominent brands such as Tylenol, Nicorette, and Zyrtec. The Skin Health and Beauty segment delivers various solutions for facial, body, hair, and sun protection, recognized under popular labels including Neutrogena, Aveeno, and OGX. Moreover, the Essential Health category provides oral hygiene, infant care, feminine wellness, and wound treatment products, marketed through esteemed brands like Listerine, Johnson's, Band-Aid, and Stayfree. Established in 2022, Kenvue Inc. maintains its corporate headquarters in Skillman, New Jersey, and operates as a subsidiary of Johnson & Johnson.
Kenvue Inc. Investment Frameworks
Invetso analyzes Kenvue Inc. (KVUE) across the following frameworks:
- Kenvue Inc. 10Y Growth Potential
- Kenvue Inc. Scenario Analysis
- Kenvue Inc. Risks & Opportunities
- Kenvue Inc. Economic Moat
- Kenvue Inc. Business Model
- Kenvue Inc. Management
- Kenvue Inc. SWOT Analysis
- Kenvue Inc. Porter's 5 Forces
- Kenvue Inc. PESTLE Analysis
- Kenvue Inc. ESG Analysis